Benchmark reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a ...
StockNews.com cut shares of SBA Communications (NASDAQ:SBAC – Free Report) from a buy rating to a hold rating in a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback